Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions

A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …

Substrate specificity of γ-secretase and other intramembrane proteases

AJ Beel, CR Sanders - Cellular and molecular life sciences, 2008 - Springer
γ-Secretase is a promiscuous protease that cleaves bitopic membrane proteins within the
lipid bilayer. Elucidating both the mechanistic basis of γ-secretase proteolysis and the …

A phase 3 trial of semagacestat for treatment of Alzheimer's disease

RS Doody, R Raman, M Farlow… - … England Journal of …, 2013 - Mass Medical Soc
Background Alzheimer's disease is characterized by the presence of cortical amyloid-beta
(Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase …

γ-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia

PJ Real, V Tosello, T Palomero, M Castillo… - Nature medicine, 2009 - nature.com
Gamma-secretase inhibitors (GSIs) block the activation of the oncogenic protein Notch
homolog-1 (NOTCH1) in T cell acute lymphoblastic leukemia (T-ALL). However, limited …

Neurotherapeutic applications of nanoparticles in Alzheimer's disease

JK Sahni, S Doggui, J Ali, S Baboota, L Dao… - Journal of Controlled …, 2011 - Elsevier
A rapid increase in incidence of neurodegenerative disorders has been observed with the
aging of the population. Alzheimer's disease (AD) is the most common neurodegenerative …

[HTML][HTML] Microvascular alterations in Alzheimer's disease

J Steinman, HS Sun, ZP Feng - Frontiers in cellular neuroscience, 2021 - frontiersin.org
Alzheimer's disease (AD) is a neurodegenerative disorder associated with continual decline
in cognition and ability to perform routine functions such as remembering familiar places or …

TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice

AF Nunes, JD Amaral, AC Lo, MB Fonseca… - Molecular …, 2012 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by accumulation of
amyloid-β (Aβ) peptide in the hippocampus and frontal cortex of the brain, leading to …

Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia

M Paganin, A Ferrando - Blood reviews, 2011 - Elsevier
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic tumor resulting
from the malignant transformation of immature T-cell progenitors. Originally associated with …

Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production

K Rezai‐Zadeh, R Douglas Shytle, Y Bai… - Journal of cellular …, 2009 - Wiley Online Library
Abstract Glycogen synthase kinase 3 (GSK‐3) dysregulation is implicated in the two
Alzheimer's disease (AD) pathological hallmarks: β‐amyloid plaques and neurofibrillary …

Challenges associated with curcumin therapy in Alzheimer disease

A Belkacemi, S Doggui, L Dao… - Expert reviews in …, 2011 - cambridge.org
Curcumin, the phytochemical agent in the spice turmeric, which gives Indian curry its yellow
colour, is also a traditional Indian medicine. It has been used for millennia as a wound …